Program

99
92
5
3
2
1
1

Journal Year Published

3
12
16
11
20
10
8
9
10
12
12
10
12
4

Author

149
201
181
139
133
133
125
123
108
105
95
82
78
63
62
54
50
46
43
43

Category

75
47
31
25
6
5
2
2
2
1
1

Keyword

58
43
32
19
18
16
15
15
14
13
13
12
12
12
11
11
10
10
10
9

Journal

16
13
12
5
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2

NCATS Publications

CD28 and ITK signals regulate autoreactive T cell trafficking.


Jain N, Miu B, Jiang J, McKinstry KK, Prince A, Swain SL, Greiner DL, Thomas C, Sanderson MJ, Berg LJ, Kang J


Nat. Med. , (19), 1632-7, 2013.

Article Pubmed

Sample image from publication page

Insulin-dependent diabetes induced by pancreatic beta cell expression of IL-15 and IL-15Rα.


Chen J, Feigenbaum L, Awasthi P, Butcher DO, Anver MR, Golubeva YG, Bamford R, Zhang X, St Claire MB, Thomas C, Discepolo V, Jabri B, Waldmann TA


Proc. Natl. Acad. Sci. U.S.A. , (110), 13534-9, 2013.

Article Pubmed

Sample image from publication page

Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome.


Rhyasen GW, Bolanos L, Fang J, Jerez A, Wunderlich M, Rigolino C, Mathews L, Ferrer-Alegre M, Southall N, Guha R, Keller J, Thomas C, Beverly LJ, Cortelezzi A, Oliva EN, Cuzzola M, Maciejewski JP, Mulloy JC, Starczynowski DT


Cancer Cell , (24), 90-104, 2013.

Article Pubmed

Sample image from publication page

Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK-mediated phosphorylation of PKM2 and metabolic reprogramming in anaplastic large cell lymphoma.


McDonnell SR, Hwang SR, Rolland D, Murga-Zamalloa C, Basrur V, Conlon KP, Fermin D, Wolfe T, Raskind A, Ruan C, Jiang J, Thomas C, Hogaboam CM, Burant CF, Elenitoba-Johnson KS, Lim MS


Blood , (122), 958-68, 2013.

Article Pubmed

Sample image from publication page

Identification of potent Yes1 kinase inhibitors using a library screening approach.


Patel PR, Sun H, Li SQ, Shen M, Khan J, Thomas C, Davis MI


Bioorg. Med. Chem. Lett. , (23), 4398-403, 2013.

Article Pubmed

Sample image from publication page

Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers.


Lin DC, Xu L, Ding LW, Sharma A, Liu L, Yang H, Tan P, Vadgama J, Karlan BY, Lester J, Urban N, Schummer M, Doan N, Said JW, Sun H, Walsh M, Thomas C, Patel P, Yin D, Chan D, Koeffler HP


Proc. Natl. Acad. Sci. U.S.A. , (110), 6109-14, 2013.

Article Pubmed

Sample image from publication page

Inhibition of ceramide metabolism sensitizes human leukemia cells to inhibition of BCL2-like proteins.


Casson L, Howell L, Mathews LA, Ferrer-Alegre M, Southall N, Guha R, Keller JM, Thomas C, Siskind LJ, Beverly LJ


PLoS ONE , (8), e54525, 2013.

Article Pubmed

Sample image from publication page

Synthesis and biological evaluation of analogues of the kinase inhibitor nilotinib as Abl and Kit inhibitors.


Duveau D, Hu X, Walsh MJ, Shukla S, Skoumbourdis AP, Boxer MB, Ambudkar SV, Shen M, Thomas C


Bioorg. Med. Chem. Lett. , (23), 682-6, 2013.

Article Pubmed

Sample image from publication page

A comparison of the ability of rilpivirine (TMC278) and selected analogues to inhibit clinically relevant HIV-1 reverse transcriptase mutants.


Johnson BC, Pauly GT, Rai Bantukallu G, Patel D, Bauman JD, Baker H, Das K, Schneider JP, Maloney DJ, Arnold E, Thomas C, Hughes SH


Retrovirology , (9), 99, 2012.

Article Pubmed

Sample image from publication page